Health Care and Biotech
Alcidion’s IT Targets Hospital Efficiency
Alcidion is an emerging operator in the field of hospital IT, with technology that can reduce deaths attributable to medical error. The stock price has doubled since it listed on ASX in February this year.
Dec 19 2016
Estia Health Beset By Uncertainty
Estia Health is beset by uncertainty surrounding the sustainability of earnings and this is not expected to moderate in the near term.
Dec 13 2016
Rebound For Sirtex
Michael Gable of Fairmont Equities suggests technically, Sirtex Medical should be set to recover.
Dec 13 2016
Sirtex Reaction Overdone
Increased competition has wedged dose sales for Sirtex Medical but brokers suspect the market’s reaction is overdone.
Dec 12 2016
Previous Stories
Merck Backs Bionomics On Alzheimer’s
Jun 25 2014
Bionomics has entered a potentially valuable deal as global Pharma giant Merck stumps up all development costs for the company’s Alzheimer’s drug.
Oz Biotech Stocks Worth Pursuing
Jun 17 2014
Baillieu Holst scrutinises positive potential across a host of Australian biotech stocks and suggests a prefered portfolio for investors.
Mayne Pharma Ahead Of Itself?
Jun 11 2014
Bell Potter initiates coverage on Mayne Pharma and takes a contrary stance to other brokers.
Cellmid Poised For Growth With Cancer Diagnostic
Jun 04 2014
Baillieu Holst takes a look at the significant upside for Cellmid’s cancer targeting technology.
Virtus Health Expands In Ireland
Jun 03 2014
Virtus Health has made its first acquisition since listing, a 70% stake in an Irish IVF clinic.
Cynata Strikes A Chord In Regenerative Medicine
Jun 03 2014
Stem cell developer Cynata Technologies has found a fan in Baillieu Holst because of the potential to revolutionise regenerative medicine.
Fisher & Paykel Healthcare Plays Safe After Record Year
May 27 2014
Fisher & Paykel Healthcare delivered a record profit in FY14 but remains cautious regarding FY15 growth, as currency hedges are due to roll off and ResMed is lurking.
Primary And Sonic Oversold?
May 26 2014
The Australian government’s plans to introduce a GP co-payment had a negative initial impact on key healthcare stocks but brokers believe panic is premature.
Weekly Broker Wrap: 4-Year Outlook, Oz Jobs, Oz M&A Targets And LICs
May 16 2014
More market volatility from 2015; Oz labour market; US corporate tax minimisation and Australian takeover targets; and Listed Investment Companies.
The Budget And The Stock Market
May 14 2014
It could have been worse, brokers agree, but there are negatives/positives for healthcare, infrastructure, retail and other sectors. Stock impacts debated.
Analyse The Market From A Different Angle
Latest News
| 1 | ASX Winners And Losers Of Today – 12-02-26Feb 12 2026 - Daily Market Reports |
| 2 | Rudi Interviewed: February Is Less About EarningsFeb 12 2026 - Rudi's View |
| 3 | FNArena Corporate Results Monitor – 12-02-2026Feb 12 2026 - Australia |
| 4 | Australian Broker Call *Extra* Edition – Feb 12, 2026Feb 12 2026 - Daily Market Reports |
| 5 | The Short Report – 12 Feb 2026Feb 12 2026 - Weekly Reports |